|
Originally published In Press as doi:10.1074/jbc.M703042200 on May 18, 2007
J. Biol. Chem., Vol. 282, Issue 29, 21206-21212, July 20, 2007
Inhibition of Phosphatidylinositol-3-OH Kinase/Akt Signaling Impairs DNA Repair in Glioblastoma Cells following Ionizing Radiation*
Gary D. Kao1,
Zibin Jiang1,
Anne Marie Fernandes,
Anjali K. Gupta, and
Amit Maity2
From the
Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104
Radiation therapy is a mainstay in the treatment of glioblastomas, but these tumors are often associated with radioresistance. Activation of the phosphatidylinositol-3-OH kinase (PI3K)/Akt pathway, which occurs frequently in glioblastomas due to inactivation of the tumor suppressor phosphatase and tensin homologue (PTEN), correlates with radioresistance. To directly test the link between Akt activation and radioresistance, we utilized PTEN-deficient U251 glioblastoma cells engineered to inducibly restore PTEN upon exposure to doxycycline. These cells showed high basal levels of Akt activation (i.e. high levels of phospho-Akt), but induction of PTEN led to substantially decreased phospho-Akt and was associated with radiosensitization. To investigate whether the PTEN-induced radiosensitization was attributable to impaired sensing versus repair of DNA damage, we assessed levels of -H2AX after ionizing radiation in U251 cells induced for PTEN. Initial post-radiation levels of -H2AX foci were not decreased in PTEN-induced cells; however, the resolution of these foci was significantly delayed. In contrast to these results, induction of phosphatase-dead PTEN showed no appreciable effect. Finally, exposure of cells to the PI3K inhibitor LY294002 did not decrease the occurrence of -H2AX foci after irradiation but did markedly delay their resolution. These results together support a direct link between Akt activation, repair of DNA damage, and radioresistance in glioblastoma. Targeting the PI3K/Akt pathway may modulate DNA repair to improve the efficacy of radiation therapy.
Received for publication, April 11, 2007
, and in revised form, May 18, 2007.
* This work was supported by Public Health Service Grants R01 CA093638 (to A. M.), R01 CA107956 (to G. D. K.), and P01CA075138 (to G. D. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 Both authors contributed equally to this work.
2 To whom correspondence should be addressed: 195 John Morgan Bldg., University of Pennsylvania School of Medicine, 3620 Hamilton Walk, Philadelphia, PA 19104. Tel.: 215-614-0078; Fax: 215-898-0090; E-mail: maity{at}xrt.upenn.edu.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Carmely, D. Meirow, A. Peretz, M. Albeck, B. Bartoov, and B. Sredni
Protective effect of the immunomodulator AS101 against cyclophosphamide-induced testicular damage in mice
Hum. Reprod.,
June 1, 2009;
24(6):
1322 - 1329.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Mukherjee, B. McEllin, C. V. Camacho, N. Tomimatsu, S. Sirasanagandala, S. Nannepaga, K. J. Hatanpaa, B. Mickey, C. Madden, E. Maher, et al.
EGFRvIII and DNA Double-Strand Break Repair: A Molecular Mechanism for Radioresistance in Glioblastoma
Cancer Res.,
May 15, 2009;
69(10):
4252 - 4259.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. L. Gallia, B. M. Tyler, C. L. Hann, I-M. Siu, V. L. Giranda, A. L. Vescovi, H. Brem, and G. J. Riggins
Inhibition of Akt inhibits growth of glioblastoma and glioblastoma stem-like cells
Mol. Cancer Ther.,
February 1, 2009;
8(2):
386 - 393.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M.-E. Sauvageot, J. L. Weatherbee, S. Kesari, S. E. Winters, J. Barnes, J. Dellagatta, N. R. Ramakrishna, C. D. Stiles, A. L.-J. Kung, M. W. Kieran, et al.
Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cells
Neuro-oncol,
January 1, 2009;
11(2):
109 - 121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Marston, V. Weston, J. Jesson, E. Maina, C. McConville, A. Agathanggelou, A. Skowronska, K. Mapp, K. Sameith, J. E. Powell, et al.
Stratification of pediatric ALL by in vitro cellular responses to DNA double-strand breaks provides insight into the molecular mechanisms underlying clinical response
Blood,
January 1, 2009;
113(1):
117 - 126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-K. I. Lau, L. B. Murray, S. S. Houshmandi, Y. Xu, D. H. Gutmann, and Q. Yu
Merlin Is a Potent Inhibitor of Glioma Growth
Cancer Res.,
July 15, 2008;
68(14):
5733 - 5742.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Prevo, E. Deutsch, O. Sampson, J. Diplexcito, K. Cengel, J. Harper, P. O'Neill, W. G. McKenna, S. Patel, and E. J. Bernhard
Class I PI3 Kinase Inhibition by the Pyridinylfuranopyrimidine Inhibitor PI-103 Enhances Tumor Radiosensitivity
Cancer Res.,
July 15, 2008;
68(14):
5915 - 5923.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Toulany, R. Kehlbach, U. Florczak, A. Sak, S. Wang, J. Chen, M. Lobrich, and H. P. Rodemann
Targeting of AKT1 enhances radiation toxicity of human tumor cells by inhibiting DNA-PKcs-dependent DNA double-strand break repair
Mol. Cancer Ther.,
July 1, 2008;
7(7):
1772 - 1781.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|